{"gene":"FXR2","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":1995,"finding":"FXR2 protein physically interacts with FMR1 (FMRP) and FXR1 both in vivo and in vitro, forming heteromers and homomers; FXR2 contains two KH domains, has RNA-binding capacity, and is localized to the cytoplasm.","method":"Co-immunoprecipitation (in vivo and in vitro interaction), RNA-binding assay, subcellular localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP in vivo and in vitro, replicated by subsequent studies, multiple orthogonal methods in single study","pmids":["7489725"],"is_preprint":false},{"year":1997,"finding":"FXR2 protein co-sediments with the 60S ribosomal subunit and is coexpressed with FMR1 and FXR1 in the cytoplasm of specific differentiated neurons in adult brain; differential expression from FMR1/FXR1 in fetal brain and testis suggests independent functions.","method":"Immunohistochemistry, subcellular fractionation/ribosome sedimentation","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fractionation and IHC in the same study, single lab but two orthogonal methods","pmids":["9259278"],"is_preprint":false},{"year":2002,"finding":"Loss of Fxr2 in knockout mice causes hyperactivity, rotarod impairment, reduced prepulse inhibition, reduced contextual fear, impaired Morris water maze performance, and reduced heat sensitivity, establishing a role for FXR2 in central nervous system function including locomotor activity, sensorimotor gating, and spatial learning.","method":"Fxr2 knockout mouse model with behavioral test battery","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular/behavioral phenotypes across multiple independent assays, replicated in subsequent studies","pmids":["11875043"],"is_preprint":false},{"year":2006,"finding":"Fmr1/Fxr2 double knockout mice display exaggerated behavioral phenotypes (hyperactivity, reduced prepulse inhibition, impaired contextual fear conditioning) compared to either single knockout, demonstrating a cooperative/epistatic genetic interaction between Fmr1 and Fxr2 in pathways controlling locomotor activity, sensorimotor gating, and cognition.","method":"Fmr1/Fxr2 double knockout mouse model, behavioral epistasis analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via double-KO with defined phenotypic readouts, littermate controls on identical background","pmids":["16675531"],"is_preprint":false},{"year":2006,"finding":"The transcription factors NF-YA, AP2, Nrf1, and Sp1 bind to the FXR2 promoter both in vitro and in vivo and positively regulate FXR2 transcription; the region upstream of the FXR2 translation start site acts as a bidirectional promoter in both neuronal and muscle cells.","method":"Gel electrophoretic mobility-shift assay (EMSA), chromatin immunoprecipitation (ChIP), co-transfection with dominant-negative transcription factors, luciferase reporter assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (EMSA, ChIP, reporter assay, dominant-negative co-transfection) in a single study establishing transcriptional regulators","pmids":["16886907"],"is_preprint":false},{"year":2010,"finding":"X-ray crystal structures of the N-terminal tandem Tudor domains of FXR2 (resolved at 1.92 Å) revealed a non-canonical nuclear localization signal with architecture similar to UHRF1; biochemical analysis showed these tandem Tudor domains preferentially recognize trimethylated peptides in a sequence-specific manner.","method":"X-ray crystallography, biochemical peptide-binding assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at 1.92 Å combined with biochemical binding validation in the same study","pmids":["21072162"],"is_preprint":false},{"year":2011,"finding":"FXR2 specifically regulates adult dentate gyrus (DG) neurogenesis by binding to and reducing the stability of Noggin mRNA; FXR2 deficiency leads to increased Noggin expression, reduced BMP signaling, and increased proliferation with altered fate specification of neural stem/progenitor cells in the DG but not the SVZ (where FXR2 is not expressed).","method":"Fxr2 knockout mouse model, mRNA stability assay, BMP signaling analysis, neural stem/progenitor cell proliferation and fate assays, regional expression analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO with defined molecular mechanism (mRNA stability), pathway placement (BMP signaling), and cell-type-specific phenotypic readout in a single rigorous study","pmids":["21658585"],"is_preprint":false},{"year":2006,"finding":"A p53/FXR2 chimeric fusion protein generated by interstitial deletion is expressed in the cytoplasm of CMK11-5 leukemia cells, whereas wild-type FXR2 localizes primarily at the periphery of the nucleus; the fusion protein loses wild-type p53 transcriptional activation function.","method":"Western blot, flag-tagged subcellular localization (immunofluorescence), transient transfection reporter assay","journal":"The Tohoku journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single lab, limited methods, but direct localization experiment with functional consequence (loss of transactivation)","pmids":["16778363"],"is_preprint":false},{"year":2019,"finding":"Fmr1 KO/Fxr2 heterozygous mice show more severe learning and memory impairments than Fmr1 KO mice alone, and the social behavior impairments of Fmr1 KO are paradoxically reversed in Fmr1 KO/Fxr2 Het mice, demonstrating that partial reduction of FXR2 modulates the Fmr1 KO phenotype in a context-dependent manner.","method":"Genetic epistasis — Fmr1 KO/Fxr2 Het double mutant mice with behavioral battery","journal":"Brain sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with defined behavioral phenotypes, single lab, multiple behavioral assays","pmids":["30654445"],"is_preprint":false},{"year":2025,"finding":"FXR2 was identified as a novel m6A reader: it binds m6A-modified RNA as demonstrated by m6A RNA pull-down assays and transcriptome-wide RBP binding site mapping, and FXR2 loss affects human embryonic stem cell differentiation without impairing self-renewal.","method":"m6A RNA pull-down assay, transcriptome-wide RBP binding site mapping (eCLIP or similar), hESC differentiation assays","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, limited mechanistic follow-up on FXR2 specifically","pmids":[],"is_preprint":true},{"year":2025,"finding":"Loss of FXR2 (but not FMR1) in HAP1 cells induces nuclear pore pathology and passive egress of proteins and RNA; cytoplasmic TDP-43 induces spontaneous stress granule formation exclusively in FXR2 knockout cells, implicating FXR2 in nuclear transport integrity and stress granule dynamics.","method":"FXR2 knockout cell model (HAP1), nuclear pore and nucleocytoplasmic transport assays, TDP-43 localization imaging, stress granule formation assay","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, cell-line model with defined phenotypic readouts but no mechanistic follow-up on the direct molecular pathway","pmids":[],"is_preprint":true}],"current_model":"FXR2 is a cytoplasmic RNA-binding protein (containing KH domains and tandem Tudor domains that recognize trimethylated peptides) that forms homo- and heteromers with FMRP and FXR1, associates with the 60S ribosomal subunit, reduces the stability of specific target mRNAs (e.g., Noggin) to regulate BMP signaling and adult hippocampal neurogenesis, cooperates genetically with FMR1 to control locomotor activity, sensorimotor gating, and cognition in vivo, and has recently been implicated in nuclear transport integrity, stress granule regulation, and m6A RNA reading."},"narrative":{"mechanistic_narrative":"FXR2 is a cytoplasmic, KH-domain RNA-binding protein that controls neuronal mRNA metabolism and central nervous system function as part of the Fragile X-related protein family [PMID:7489725, PMID:11875043]. It physically associates with FMRP (FMR1) and FXR1 to form homo- and heteromers and co-sediments with the 60S ribosomal subunit, placing it at the translational machinery in differentiated neurons [PMID:7489725, PMID:9259278]. Mechanistically, FXR2 binds and destabilizes specific target mRNAs: it reduces the stability of Noggin mRNA, thereby sustaining BMP signaling and constraining proliferation and fate specification of neural stem/progenitor cells in the adult dentate gyrus [PMID:21658585]. In vivo, Fxr2 loss produces hyperactivity, impaired sensorimotor gating, and deficits in spatial learning and contextual fear, and Fxr2 interacts genetically with Fmr1, with combined loss yielding exaggerated behavioral phenotypes—establishing cooperative control of locomotion, gating, and cognition [PMID:11875043, PMID:16675531]. Structurally, its N-terminal tandem Tudor domains adopt a UHRF1-like architecture that encodes a non-canonical nuclear localization signal and selectively recognizes trimethylated peptides [PMID:21072162]. FXR2 transcription is driven by a bidirectional promoter bound and activated by NF-YA, AP2, Nrf1, and Sp1 [PMID:16886907].","teleology":[{"year":1995,"claim":"Established FXR2 as a member of the Fragile X-related family by showing it physically partners with FMRP and FXR1 and itself binds RNA, defining the molecular context in which it acts.","evidence":"Reciprocal co-immunoprecipitation in vivo and in vitro, RNA-binding assay, and subcellular localization","pmids":["7489725"],"confidence":"High","gaps":["Did not identify specific RNA targets","Functional consequence of heteromer formation not defined"]},{"year":1997,"claim":"Linked FXR2 to the translational apparatus and to specific neurons, suggesting a role in neuronal mRNA handling that is partly independent of FMR1/FXR1.","evidence":"Ribosome sedimentation/subcellular fractionation and immunohistochemistry in adult brain","pmids":["9259278"],"confidence":"Medium","gaps":["Whether ribosome association reflects active translational regulation not shown","Independent functions inferred from expression pattern, not tested directly"]},{"year":2002,"claim":"Demonstrated that FXR2 is required in vivo for CNS function, moving the protein from a biochemical interactor to a physiological regulator of behavior.","evidence":"Fxr2 knockout mice subjected to a behavioral test battery","pmids":["11875043"],"confidence":"High","gaps":["Molecular targets underlying behavioral deficits not identified","Cell types and circuits responsible not resolved"]},{"year":2006,"claim":"Showed that FXR2 and FMR1 act cooperatively in shared behavioral pathways, indicating functional overlap within the family beyond simple physical interaction.","evidence":"Fmr1/Fxr2 double knockout mice with behavioral epistasis analysis","pmids":["16675531"],"confidence":"High","gaps":["Shared molecular targets driving epistasis unknown","Whether cooperation occurs at the level of mRNA binding not addressed"]},{"year":2006,"claim":"Defined the transcriptional control of FXR2, identifying activators and a bidirectional promoter architecture.","evidence":"EMSA, ChIP, dominant-negative co-transfection, and luciferase reporter assays in neuronal and muscle cells","pmids":["16886907"],"confidence":"High","gaps":["Identity of the gene transcribed from the opposite promoter direction not characterized in this dataset","Regulation of FXR2 expression in disease states not addressed"]},{"year":2010,"claim":"Provided atomic-level insight into FXR2 domains, revealing a UHRF1-like tandem Tudor module that reads trimethylated peptides and harbors a non-canonical NLS.","evidence":"X-ray crystallography at 1.92 Å with biochemical peptide-binding assays","pmids":["21072162"],"confidence":"High","gaps":["Physiological trimethylated ligand not identified","Functional role of the non-canonical NLS in cells not tested"]},{"year":2011,"claim":"Defined a concrete molecular mechanism: FXR2 destabilizes Noggin mRNA to set BMP signaling levels and thereby control adult dentate gyrus neurogenesis.","evidence":"Fxr2 knockout mice with mRNA stability assays, BMP pathway analysis, and region-specific neural stem/progenitor proliferation and fate assays","pmids":["21658585"],"confidence":"High","gaps":["Whether other target mRNAs contribute not established","Mechanism by which FXR2 binding triggers destabilization unknown"]},{"year":2006,"claim":"Captured a disease-associated p53/FXR2 fusion, incidentally indicating wild-type FXR2 localizes at the nuclear periphery in this cell context.","evidence":"Western blot, immunofluorescence of FLAG-tagged constructs, and transactivation reporter assay in leukemia cells","pmids":["16778363"],"confidence":"Medium","gaps":["Single cell-line observation","Relevance of nuclear-periphery localization to normal FXR2 function unclear"]},{"year":2019,"claim":"Refined the FXR2–FMR1 genetic relationship, showing partial FXR2 reduction modulates Fmr1 KO phenotypes in a context-dependent, sometimes opposing manner.","evidence":"Fmr1 KO/Fxr2 heterozygous double-mutant mice with behavioral battery","pmids":["30654445"],"confidence":"Medium","gaps":["Mechanism of the paradoxical social-behavior reversal unknown","Dosage-dependent molecular effects not defined"]},{"year":2025,"claim":"Proposed new molecular roles for FXR2 as an m6A reader and as a guardian of nuclear transport and stress granule homeostasis, extending its function beyond cytoplasmic mRNA destabilization.","evidence":"m6A RNA pull-down and transcriptome-wide RBP mapping with hESC differentiation assays; FXR2 knockout HAP1 cells with nuclear pore, nucleocytoplasmic transport, TDP-43, and stress granule assays (both preprints)","pmids":[],"confidence":"Low","gaps":["Preprint, single lab, not independently confirmed","Direct molecular link between FXR2 and nuclear pore integrity not established","m6A-binding determinants on FXR2 not mapped"]},{"year":null,"claim":"The full repertoire of FXR2 target mRNAs and the biochemical mechanism connecting its RNA binding, ribosome association, Tudor-mediated methyl-peptide reading, and proposed m6A/nuclear-transport roles into one pathway remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No genome-wide validated target set in neurons","Link between Tudor methyl-reading and mRNA regulation unknown","m6A reader and nuclear-transport roles await peer-reviewed confirmation"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,6]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[6]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[1]}],"pathway":[],"complexes":[],"partners":["FMR1","FXR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51116","full_name":"RNA-binding protein FXR2","aliases":["FMR1 autosomal homolog 2"],"length_aa":673,"mass_kda":74.2,"function":"mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for adult hippocampal neurogenesis (By similarity). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs: mRNAs storage into membraneless compartments regulates their translation and/or stability (By similarity). Acts as a regulator of adult hippocampal neurogenesis by regulating translation and/or stability of NOG mRNA, thereby preventing NOG protein expression in the dentate gyrus (By similarity)","subcellular_location":"Cytoplasm, Cytoplasmic ribonucleoprotein granule; Cytoplasm; Postsynapse","url":"https://www.uniprot.org/uniprotkb/P51116/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FXR2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000129245","cell_line_id":"CID001514","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"LSM14A","stoichiometry":10.0},{"gene":"CAPRIN1","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"PSPC1","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"RBM42","stoichiometry":0.2},{"gene":"RPS16","stoichiometry":0.2},{"gene":"SRP68","stoichiometry":0.2},{"gene":"TOP2A","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001514","total_profiled":1310},"omim":[{"mim_id":"614392","title":"TUDOR DOMAIN-CONTAINING PROTEIN 3; TDRD3","url":"https://www.omim.org/entry/614392"},{"mim_id":"613776","title":"CHROMOSOME 17p13.1 DELETION SYNDROME","url":"https://www.omim.org/entry/613776"},{"mim_id":"605339","title":"FMR1 AUTOSOMAL HOMOLOG 2; FXR2","url":"https://www.omim.org/entry/605339"},{"mim_id":"604354","title":"NUCLEAR FMRP-INTERACTING PROTEIN 1; NUFIP1","url":"https://www.omim.org/entry/604354"},{"mim_id":"600819","title":"FMR1 AUTOSOMAL HOMOLOG 1; FXR1","url":"https://www.omim.org/entry/600819"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":113.4}],"url":"https://www.proteinatlas.org/search/FXR2"},"hgnc":{"alias_symbol":[],"prev_symbol":["FMR1L2"]},"alphafold":{"accession":"P51116","domains":[{"cath_id":"-","chopping":"13-200","consensus_level":"medium","plddt":90.55,"start":13,"end":200},{"cath_id":"3.30.1370.10","chopping":"228-287","consensus_level":"high","plddt":93.487,"start":228,"end":287},{"cath_id":"3.30.1370.10","chopping":"293-386","consensus_level":"high","plddt":89.4072,"start":293,"end":386}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51116","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51116-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51116-F1-predicted_aligned_error_v6.png","plddt_mean":68.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FXR2","jax_strain_url":"https://www.jax.org/strain/search?query=FXR2"},"sequence":{"accession":"P51116","fasta_url":"https://rest.uniprot.org/uniprotkb/P51116.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51116/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51116"}},"corpus_meta":[{"pmid":"7489725","id":"PMC_7489725","title":"The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7489725","citation_count":272,"is_preprint":false},{"pmid":"9259278","id":"PMC_9259278","title":"Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis.","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9259278","citation_count":163,"is_preprint":false},{"pmid":"16675531","id":"PMC_16675531","title":"Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16675531","citation_count":94,"is_preprint":false},{"pmid":"11875043","id":"PMC_11875043","title":"Knockout mouse model for Fxr2: a model for mental retardation.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11875043","citation_count":88,"is_preprint":false},{"pmid":"21658585","id":"PMC_21658585","title":"RNA-binding protein FXR2 regulates adult hippocampal neurogenesis by reducing Noggin expression.","date":"2011","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/21658585","citation_count":78,"is_preprint":false},{"pmid":"11735223","id":"PMC_11735223","title":"Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11735223","citation_count":67,"is_preprint":false},{"pmid":"21072162","id":"PMC_21072162","title":"Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21072162","citation_count":45,"is_preprint":false},{"pmid":"10446811","id":"PMC_10446811","title":"Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissues.","date":"1999","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10446811","citation_count":43,"is_preprint":false},{"pmid":"28767039","id":"PMC_28767039","title":"FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28767039","citation_count":31,"is_preprint":false},{"pmid":"30654445","id":"PMC_30654445","title":"Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice.","date":"2019","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30654445","citation_count":10,"is_preprint":false},{"pmid":"18930145","id":"PMC_18930145","title":"Genes and pathways differentially expressed in the brains of Fxr2 knockout mice.","date":"2008","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/18930145","citation_count":10,"is_preprint":false},{"pmid":"16886907","id":"PMC_16886907","title":"NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2).","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16886907","citation_count":9,"is_preprint":false},{"pmid":"8697816","id":"PMC_8697816","title":"Ordering of 66 STSs along the entire short arm of human chromosome 17 and chromosome assignment of a transcribed sequence (FMR1L2) homologous to FMR1.","date":"1996","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8697816","citation_count":8,"is_preprint":false},{"pmid":"39800017","id":"PMC_39800017","title":"5-Methylcytosine-modified circRNA-CCNL2 regulates vascular remdeling in hypoxic pulmonary hypertension through binding to FXR2.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39800017","citation_count":7,"is_preprint":false},{"pmid":"16778363","id":"PMC_16778363","title":"Cloning and characterization of the novel chimeric gene p53/FXR2 in the acute megakaryoblastic leukemia cell line CMK11-5.","date":"2006","source":"The Tohoku journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16778363","citation_count":4,"is_preprint":false},{"pmid":"40149453","id":"PMC_40149453","title":"Clinical Significance of Fragile X Syndrome 2 (FXR2) in Breast Cancer.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40149453","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.27.684798","title":"Loss of FXR1 and FXR2 promotes accumulation of TDP-43 in aging-related stress granules","date":"2025-10-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.27.684798","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.30.691455","title":"Alphaviral nonstructural protein-host RBP co-condensation as a mechanism to sustain virus replication","date":"2025-12-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.30.691455","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.09.640963","title":"Comprehensive profiling of  <i>N</i>  <sup>6</sup>  -methyladnosine (m  <sup>6</sup>  A) readouts reveals novel m  <sup>6</sup>  A readers that regulate human embryonic stem cell differentiation","date":"2025-03-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.09.640963","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11394,"output_tokens":2609,"usd":0.036658,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9827,"output_tokens":3114,"usd":0.063492,"stage2_stop_reason":"end_turn"},"total_usd":0.10015,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"FXR2 protein physically interacts with FMR1 (FMRP) and FXR1 both in vivo and in vitro, forming heteromers and homomers; FXR2 contains two KH domains, has RNA-binding capacity, and is localized to the cytoplasm.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro interaction), RNA-binding assay, subcellular localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP in vivo and in vitro, replicated by subsequent studies, multiple orthogonal methods in single study\",\n      \"pmids\": [\"7489725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"FXR2 protein co-sediments with the 60S ribosomal subunit and is coexpressed with FMR1 and FXR1 in the cytoplasm of specific differentiated neurons in adult brain; differential expression from FMR1/FXR1 in fetal brain and testis suggests independent functions.\",\n      \"method\": \"Immunohistochemistry, subcellular fractionation/ribosome sedimentation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation and IHC in the same study, single lab but two orthogonal methods\",\n      \"pmids\": [\"9259278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Loss of Fxr2 in knockout mice causes hyperactivity, rotarod impairment, reduced prepulse inhibition, reduced contextual fear, impaired Morris water maze performance, and reduced heat sensitivity, establishing a role for FXR2 in central nervous system function including locomotor activity, sensorimotor gating, and spatial learning.\",\n      \"method\": \"Fxr2 knockout mouse model with behavioral test battery\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular/behavioral phenotypes across multiple independent assays, replicated in subsequent studies\",\n      \"pmids\": [\"11875043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Fmr1/Fxr2 double knockout mice display exaggerated behavioral phenotypes (hyperactivity, reduced prepulse inhibition, impaired contextual fear conditioning) compared to either single knockout, demonstrating a cooperative/epistatic genetic interaction between Fmr1 and Fxr2 in pathways controlling locomotor activity, sensorimotor gating, and cognition.\",\n      \"method\": \"Fmr1/Fxr2 double knockout mouse model, behavioral epistasis analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via double-KO with defined phenotypic readouts, littermate controls on identical background\",\n      \"pmids\": [\"16675531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The transcription factors NF-YA, AP2, Nrf1, and Sp1 bind to the FXR2 promoter both in vitro and in vivo and positively regulate FXR2 transcription; the region upstream of the FXR2 translation start site acts as a bidirectional promoter in both neuronal and muscle cells.\",\n      \"method\": \"Gel electrophoretic mobility-shift assay (EMSA), chromatin immunoprecipitation (ChIP), co-transfection with dominant-negative transcription factors, luciferase reporter assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (EMSA, ChIP, reporter assay, dominant-negative co-transfection) in a single study establishing transcriptional regulators\",\n      \"pmids\": [\"16886907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"X-ray crystal structures of the N-terminal tandem Tudor domains of FXR2 (resolved at 1.92 Å) revealed a non-canonical nuclear localization signal with architecture similar to UHRF1; biochemical analysis showed these tandem Tudor domains preferentially recognize trimethylated peptides in a sequence-specific manner.\",\n      \"method\": \"X-ray crystallography, biochemical peptide-binding assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at 1.92 Å combined with biochemical binding validation in the same study\",\n      \"pmids\": [\"21072162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FXR2 specifically regulates adult dentate gyrus (DG) neurogenesis by binding to and reducing the stability of Noggin mRNA; FXR2 deficiency leads to increased Noggin expression, reduced BMP signaling, and increased proliferation with altered fate specification of neural stem/progenitor cells in the DG but not the SVZ (where FXR2 is not expressed).\",\n      \"method\": \"Fxr2 knockout mouse model, mRNA stability assay, BMP signaling analysis, neural stem/progenitor cell proliferation and fate assays, regional expression analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined molecular mechanism (mRNA stability), pathway placement (BMP signaling), and cell-type-specific phenotypic readout in a single rigorous study\",\n      \"pmids\": [\"21658585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A p53/FXR2 chimeric fusion protein generated by interstitial deletion is expressed in the cytoplasm of CMK11-5 leukemia cells, whereas wild-type FXR2 localizes primarily at the periphery of the nucleus; the fusion protein loses wild-type p53 transcriptional activation function.\",\n      \"method\": \"Western blot, flag-tagged subcellular localization (immunofluorescence), transient transfection reporter assay\",\n      \"journal\": \"The Tohoku journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, limited methods, but direct localization experiment with functional consequence (loss of transactivation)\",\n      \"pmids\": [\"16778363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Fmr1 KO/Fxr2 heterozygous mice show more severe learning and memory impairments than Fmr1 KO mice alone, and the social behavior impairments of Fmr1 KO are paradoxically reversed in Fmr1 KO/Fxr2 Het mice, demonstrating that partial reduction of FXR2 modulates the Fmr1 KO phenotype in a context-dependent manner.\",\n      \"method\": \"Genetic epistasis — Fmr1 KO/Fxr2 Het double mutant mice with behavioral battery\",\n      \"journal\": \"Brain sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with defined behavioral phenotypes, single lab, multiple behavioral assays\",\n      \"pmids\": [\"30654445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FXR2 was identified as a novel m6A reader: it binds m6A-modified RNA as demonstrated by m6A RNA pull-down assays and transcriptome-wide RBP binding site mapping, and FXR2 loss affects human embryonic stem cell differentiation without impairing self-renewal.\",\n      \"method\": \"m6A RNA pull-down assay, transcriptome-wide RBP binding site mapping (eCLIP or similar), hESC differentiation assays\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, limited mechanistic follow-up on FXR2 specifically\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Loss of FXR2 (but not FMR1) in HAP1 cells induces nuclear pore pathology and passive egress of proteins and RNA; cytoplasmic TDP-43 induces spontaneous stress granule formation exclusively in FXR2 knockout cells, implicating FXR2 in nuclear transport integrity and stress granule dynamics.\",\n      \"method\": \"FXR2 knockout cell model (HAP1), nuclear pore and nucleocytoplasmic transport assays, TDP-43 localization imaging, stress granule formation assay\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, cell-line model with defined phenotypic readouts but no mechanistic follow-up on the direct molecular pathway\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"FXR2 is a cytoplasmic RNA-binding protein (containing KH domains and tandem Tudor domains that recognize trimethylated peptides) that forms homo- and heteromers with FMRP and FXR1, associates with the 60S ribosomal subunit, reduces the stability of specific target mRNAs (e.g., Noggin) to regulate BMP signaling and adult hippocampal neurogenesis, cooperates genetically with FMR1 to control locomotor activity, sensorimotor gating, and cognition in vivo, and has recently been implicated in nuclear transport integrity, stress granule regulation, and m6A RNA reading.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FXR2 is a cytoplasmic, KH-domain RNA-binding protein that controls neuronal mRNA metabolism and central nervous system function as part of the Fragile X-related protein family [#0, #2]. It physically associates with FMRP (FMR1) and FXR1 to form homo- and heteromers and co-sediments with the 60S ribosomal subunit, placing it at the translational machinery in differentiated neurons [#0, #1]. Mechanistically, FXR2 binds and destabilizes specific target mRNAs: it reduces the stability of Noggin mRNA, thereby sustaining BMP signaling and constraining proliferation and fate specification of neural stem/progenitor cells in the adult dentate gyrus [#6]. In vivo, Fxr2 loss produces hyperactivity, impaired sensorimotor gating, and deficits in spatial learning and contextual fear, and Fxr2 interacts genetically with Fmr1, with combined loss yielding exaggerated behavioral phenotypes—establishing cooperative control of locomotion, gating, and cognition [#2, #3]. Structurally, its N-terminal tandem Tudor domains adopt a UHRF1-like architecture that encodes a non-canonical nuclear localization signal and selectively recognizes trimethylated peptides [#5]. FXR2 transcription is driven by a bidirectional promoter bound and activated by NF-YA, AP2, Nrf1, and Sp1 [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established FXR2 as a member of the Fragile X-related family by showing it physically partners with FMRP and FXR1 and itself binds RNA, defining the molecular context in which it acts.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation in vivo and in vitro, RNA-binding assay, and subcellular localization\",\n      \"pmids\": [\"7489725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify specific RNA targets\", \"Functional consequence of heteromer formation not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Linked FXR2 to the translational apparatus and to specific neurons, suggesting a role in neuronal mRNA handling that is partly independent of FMR1/FXR1.\",\n      \"evidence\": \"Ribosome sedimentation/subcellular fractionation and immunohistochemistry in adult brain\",\n      \"pmids\": [\"9259278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ribosome association reflects active translational regulation not shown\", \"Independent functions inferred from expression pattern, not tested directly\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated that FXR2 is required in vivo for CNS function, moving the protein from a biochemical interactor to a physiological regulator of behavior.\",\n      \"evidence\": \"Fxr2 knockout mice subjected to a behavioral test battery\",\n      \"pmids\": [\"11875043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets underlying behavioral deficits not identified\", \"Cell types and circuits responsible not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed that FXR2 and FMR1 act cooperatively in shared behavioral pathways, indicating functional overlap within the family beyond simple physical interaction.\",\n      \"evidence\": \"Fmr1/Fxr2 double knockout mice with behavioral epistasis analysis\",\n      \"pmids\": [\"16675531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Shared molecular targets driving epistasis unknown\", \"Whether cooperation occurs at the level of mRNA binding not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the transcriptional control of FXR2, identifying activators and a bidirectional promoter architecture.\",\n      \"evidence\": \"EMSA, ChIP, dominant-negative co-transfection, and luciferase reporter assays in neuronal and muscle cells\",\n      \"pmids\": [\"16886907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the gene transcribed from the opposite promoter direction not characterized in this dataset\", \"Regulation of FXR2 expression in disease states not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided atomic-level insight into FXR2 domains, revealing a UHRF1-like tandem Tudor module that reads trimethylated peptides and harbors a non-canonical NLS.\",\n      \"evidence\": \"X-ray crystallography at 1.92 Å with biochemical peptide-binding assays\",\n      \"pmids\": [\"21072162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trimethylated ligand not identified\", \"Functional role of the non-canonical NLS in cells not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined a concrete molecular mechanism: FXR2 destabilizes Noggin mRNA to set BMP signaling levels and thereby control adult dentate gyrus neurogenesis.\",\n      \"evidence\": \"Fxr2 knockout mice with mRNA stability assays, BMP pathway analysis, and region-specific neural stem/progenitor proliferation and fate assays\",\n      \"pmids\": [\"21658585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other target mRNAs contribute not established\", \"Mechanism by which FXR2 binding triggers destabilization unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Captured a disease-associated p53/FXR2 fusion, incidentally indicating wild-type FXR2 localizes at the nuclear periphery in this cell context.\",\n      \"evidence\": \"Western blot, immunofluorescence of FLAG-tagged constructs, and transactivation reporter assay in leukemia cells\",\n      \"pmids\": [\"16778363\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell-line observation\", \"Relevance of nuclear-periphery localization to normal FXR2 function unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Refined the FXR2–FMR1 genetic relationship, showing partial FXR2 reduction modulates Fmr1 KO phenotypes in a context-dependent, sometimes opposing manner.\",\n      \"evidence\": \"Fmr1 KO/Fxr2 heterozygous double-mutant mice with behavioral battery\",\n      \"pmids\": [\"30654445\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of the paradoxical social-behavior reversal unknown\", \"Dosage-dependent molecular effects not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proposed new molecular roles for FXR2 as an m6A reader and as a guardian of nuclear transport and stress granule homeostasis, extending its function beyond cytoplasmic mRNA destabilization.\",\n      \"evidence\": \"m6A RNA pull-down and transcriptome-wide RBP mapping with hESC differentiation assays; FXR2 knockout HAP1 cells with nuclear pore, nucleocytoplasmic transport, TDP-43, and stress granule assays (both preprints)\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Preprint, single lab, not independently confirmed\", \"Direct molecular link between FXR2 and nuclear pore integrity not established\", \"m6A-binding determinants on FXR2 not mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The full repertoire of FXR2 target mRNAs and the biochemical mechanism connecting its RNA binding, ribosome association, Tudor-mediated methyl-peptide reading, and proposed m6A/nuclear-transport roles into one pathway remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No genome-wide validated target set in neurons\", \"Link between Tudor methyl-reading and mRNA regulation unknown\", \"m6A reader and nuclear-transport roles await peer-reviewed confirmation\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0112316\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FMR1\",\n      \"FXR1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}